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Abstract  
Introduction: Chronic Lymphocytic Leukemia (CLL) is a disease with highly heterogeneous clinical 
course. A key goal is the prediction of patients with high risk of disease progression, which could 
benefit from an earlier or more intense treatment. In this work we introduce a simple methodology 
based on machine learning methods to help physicians in their decision making in different problems 
related to CLL. Material and Methods: Clinical data belongs to a retrospective study of a cohort of 
265 Caucasians who were diagnosed with CLL between 1997 and 2007 in Hospital Cabueñes 
(Asturias, Spain). Different machine learning methods were applied to find the shortest list of most 
discriminatory prognostic variables to predict the need of Chemotherapy Treatment and the 
development of an Autoimmune Disease. Results: Autoimmune disease occurrence was predicted with 
very high accuracy (>90%). Autoimmune disease development is currently an unpredictable severe 
complication of CLL. Chemotherapy Treatment has been predicted with a lower accuracy (80%). Risk 
analysis showed that the number of false positives and false negatives are well balanced. Conclusions: 
Our study highlights the importance of prognostic variables associated with the characteristics of 
platelets, reticulocytes and natural killers, which are the main targets of the autoimmune haemolytic 
anemia and immune thrombocytopenia for autoimmune disease development, and also, the relevance 
of some clinical variables related with the immune characteristics of CLL patients that are not taking 
into account by current prognostic markers for predicting the need of chemotherapy. Because of its 
simplicity, this methodology could be implemented in spreadsheets. 
Keywords: Chronic Lymphocytic Leukemia; chemotherapy treatment; autoimmune disease 
development; machine learning. 
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1. INTRODUCTION 
Chronic Lymphocytic Leukemia (CLL) is the most common adult Leukemia in 
western countries, and it is characterized by the accumulation of malignant B-cells in 
blood and lymphoid organs. The clinical course of CLL is highly heterogeneous since 
the survival of some patients is only slightly affected by the disease, whereas other 
patients have a progressive disease associated with infectious and autoimmune 
complications. These progressive patients have poor prognosis, but they could benefit 
from an earlier or more intense chemotherapeutic treatment. It has been reported that 
many poor prognostic factors (including CD38, ZAP-70, β2-microglobulin, IgVH 
mutation status and deletions of 11q23 or 17p53) may help to identify high-risk 
patients at early stages [1 - 6]. Most of these prognostic factors focus on the analysis 
of the characteristics of malignant leukemia cells. Additionally, the characteristics of 
the immune system of CLL patients, such as the number of CD8 and CD4-T cells at 
diagnosis, may also predict the progression of the disease [6]. Nevertheless, due to 
their high cost and complexity some of these prognostic factors are not used in most 
hospitals on regular basis. To overcome this problem in the clinical practice staging 
systems using few, simple, cheap and accessible clinical variables have been 
popularized. The Rai staging system [7] and the Binet classification [8] are useful to 
predict the prognosis of CLL patients, to stratify them, and to achieve comparisons for 
interpreting specific treatment results. Staging systems stratify subsets of patients who 
have significant differences in the overall survival but they fail to identify patients 
who have a high risk of progression in early stages of the disease. Additionally, no 
current prognostic factors exist to predict the development of some severe 
complications such as the development of Autoimmune Diseases (AD), or the need 
for chemotherapy. Consequently, the identification of currently available clinical 
variables to assess the medical decisions in these CLL-related diagnosis problems is a 
key goal in the management of this disease. The development of AD or the need of 
CT is not known at diagnosis. So far, only with the evolution of the patient during the 
5 years follow up, medical doctors can answer these questions. Therefore, the interest 
of the methodology presented herein consists in being able of predicting both CLL 
related problems at diagnosis. Particularly, AD problem was very hard to predict, and 
up to our knowledge no previous research was successful to explain this phenomenon 
using biochemical variables. 
In this paper we show whether machine learning methods and clinical data 
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obtained from a large population of well-studied CLL patients [6] can be efficiently 
applied to address these CLL diagnosis problems in medical practice by capturing the 
hidden implicit relationships between the clinical variables and the corresponding 
class of the different patients that have been established by medical experts. The use 
of machine learning techniques [9] in clinical medicine [10] and in cancer prediction 
and prognosis [11] is not new, and it has the advantage of treating more general 
prediction problems than survival analysis (usually treated through the Kaplan-Meier 
estimator) as supervised classification problems that admit more stable solutions than 
the corresponding regression problems.  
The machine learning methodologies that are proposed in this paper are simple 
in their design and serve to provide to the physicians a simple and robust decision-
making support system. Other more complex algorithms could be used, but the goal 
of this work is to obtain a simple decision rule and not to compare different learning 
algorithms. This manuscript is structured in three main parts. Firstly we provide an 
exhaustive explanation of the methods. Secondly, we present the results obtained for 
the two clinical CLL-related problems addressed herein: need of Chemotherapy 
Treatment (CT) and Autoimmune Disease development (AD). Finally, we provide 
coherent explanations and discussion of the findings.  
 
2. MATERIAL AND METHODS 
A cohort of two hundred sixty-five Caucasians who were diagnosed in the 
Cabueñes Hospital (Gijón, Spain) with CLL between 1997 and 2009 were enrolled in 
this study. The population distribution by gender and age is the following: 154 are 
males and 111 are females, with ages ranging from 42 to 92, and 47 to 94 years old 
respectively. Clinical characteristics of patients including time for diagnosis to first 
treatment, need of chemotherapy treatment and appearance of autoimmune 
complications were also taken into account in this study. Additionally, thirty-six 
different clinical and biological variables were measured at diagnosis of the disease. 
Table 1 shows the variables description used in this study. Some variables reflect the 
malignant characteristic of leukemia cells; others measure the immunological 
characteristics of CLL patients, and some may be associated with the presence or 
development of autoimmune complications (autoimmune haemolytic anemia and 
immune-thrombocytopenia). Finally, some of the variables are demographic and 
biochemical. Most of them have a sampling frequency higher than 80%, however, the 
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reticulocyte count (RET) and ZAP-70 are the ones that show the lowest sampling 
frequency. Particularly, ZAP-70 is only sampled in 21.9% of the patients (58 out of 
265), showing that this popular CLL prognostic factor is not always available in 
medical practice. Although some of these variables were not at disposal at diagnosis 
(LD for instance), they have been used for analysis purposes. We provide the database 
as supplementary material (see “CLL.xls”). 
The problems to be solved in this manuscript are the prediction of the need for 
Chemotherapy Treatment (CT) and the development of Autoimmune Disease (AD). 
Both classification problems are binary (two class classification problem). In our 
methodology we have explored the minimum-size list of prognostic variables (named 
as reduced base) having the highest predictive accuracy using different feature 
selection methods. The selected prognostic variables will be subsequently used for 
diagnosis and prognosis.  
Figure 1 shows the flowchart of the methodology, that includes 4 different steps:  
2.1. Data Preprocessing 
Data preprocessing is applied to improve the quality of data used for performing 
feature selection, prediction and optimization. It includes two main sub steps that can 
be applied or not depending on their impact on the prediction:  
• Filtering: All the features that were sampled less than a certain sampling 
frequency are removed. The filtering cut offs used were 30, 40 and 50%. 
• Imputation: This technique consists in interpolating all the missing values 
using a Nearest-Neighbor algorithm [12]. Given a partially-informed sample 
(with missing values) the algorithm finds the closest sample within the set of 
fully-informed samples and gives the values of the missing variables in this 
closest sample to the imputed sample. The similarity between samples is 
measured using the standard Euclidean dot product in N-dimensional vector 
spaces, where N is the number of fully-informed variables. This way of 
interpolation has the advantage of not introducing additional outliers that are 
not originally present in the dataset before imputation. Although the success 
of the different imputed algorithms might be data-driven, imputing the data 
improved the accuracy in the predictions and did not alter the prognostic 
variables that were involved providing shorter lists with higher 
discriminatory power. 
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2.2. Feature Selection methods  
Maximum Fisher’s ratio [13,14]: The Fisher’s ratio of an attribute j, in a 
two-class problem, 1 2,c c , is defined as follows: 
( )21 2
1 2 2 2
1 2
( , ) ,j jj
j j
GFR c c
µ µ
σ σ
−
=
+
 
where, 1 2,j jµ µ  are measures of the center of the distribution (means) of gene 
j in classes 1 and 2, and 2 21 2,j jσ σ  are measures of the dispersion (variance) 
within these classes. This method looks for prognostic variables that separate 
the classes further apart and are very homogeneous within classes (low intra 
class variance). 
Minimum class Entropy [15, 16]: Entropy is a measure of the number of 
specific ways in which a system may be rearranged, and it is often 
considered a measure of disorder, or progression towards thermodynamic 
equilibrium. In the case of a binary classification problem, the entropy of 
each attribute is defined as follows:  
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where CN  are the number of bins used to describe the probability 
distribution of attribute j in class k, and kjp  is the probability that this 
attribute takes the center class value .kjx  The algorithm to compute the 
entropy is based in ordering the variables according to their value and 
calculating the mismatch to the class vector. A perfect ordering occurs when 
the values correspond perfectly to the class vector. Variables with higher 
ordering (or lower entropy) are therefore the most discriminatory.  
Maximum Percentile Distance: This feature selection method selects the 
attributes with higher distances between the corresponding cumulative 
probability functions (percentile array) within each class, defined for 
attribute j as follows:  
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where jip  stands for the percentile vector j in class i, and  2jip its Euclidean 
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norm. Percentiles vary from 5 to 95 to avoid the possible effect of outliers 
[17]. This method can be considered as a generalization of a Mann-Whitney 
selection test, which is only based in the median (percentile 50). 
The main reason for choosing these methods is due their clear interpretation, low 
computational cost, and the possibility of being applied to both, discrete and 
continuous variables. A survey about FS methods can be consulted in [18]. 
2.3. Accuracy evaluation  
Once the most discriminatory variables are determined and ranked in decreasing 
order by their discriminatory power, the aim is to determine the shortest (having the 
smallest number of variables) list of prognostic variables with the highest predictive 
accuracy. The algorithm to find the minimum-size list of features is the Backwards 
Feature Elimination (BFE), which is similar to the Recursive Feature Elimination 
[19]. Feature elimination tries to unravel the existence of redundant or irrelevant 
features to yield the smallest set of prognostic variables that provide the greatest 
possible classification accuracy. Redundant features are those that provide no 
additional information than the currently selected features, while irrelevant features 
provide no useful information in any context. 
The algorithm of BFE works as follows: 
1. Beginning by the tail of the ranked list of prognostic variables, the algorithm 
iteratively generates increasingly shorter lists by eliminating one prognostic 
variable at a time, calculating their classification accuracy.  
2. Finally, the list with the optimum accuracy and minimum size is therefore 
selected.  
This way of proceeding is based on the following idea: prognostic variables with 
higher discriminatory ratios span low frequency features of the classification, whilst 
variables with lowest discriminatory ratios account for the details in the 
discrimination (high frequency features). This method determines the minimum 
amount of high frequency details that are needed to optimally discriminate between 
classes. 
The predictive accuracy estimation is based on a Leave One Out Cross-
Validation experiment (LOOCV), using the average distance of the reduced set of 
features to each training class set. The goal of cross-validation is to estimate 
how accurately a predictive model (classifier) will perform in practice. LOOCV 
involves using a single sample from the original dataset as the validation data (sample 
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test), and the remaining samples as training data. The class assignment is based in a 
nearest-neighbor classifier in the reduced base, that is, the class with the minimum 
distance in the reduced base to the sample test is assigned to the sample test. The 
average LOOCV predictive accuracy is calculated by iterating over all the samples 
using as metric the Euclidean distance between the corresponding normalized 
variables. For that purpose the weights used to normalize the variables are the inverse 
of two times the prior variability (standard deviation) of the prognostic variables. 
These weights serve to scale the different kinds of measurements into approximately 
the same range in order to give to each variable a similar influence on the overall 
distance measurement. The distance between a new sample news  and the average 
signature jm  in class j is: 
( ) ( )
2
, ,new j new jd W= −s m s m  
with W is a diagonal matrix with 1( , )
2 ( )k
W k k
std v
= , where ( )kstd v  is the standard 
deviation of the k-th discriminatory prognostic variable. 
In this procedure the feature selection method is executed only once using all training 
samples before estimating the accuracy by means of a leave-one-out procedure. For 
each new sample the classifier computes the average distance to the training samples 
of each class, being 1d  the average distance to class 1, and 2d  the average distance to 
class 2.  
Based on these distances the probability of a new sample news  to be in class 1 can be 
written as:  
( ) 21
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The procedure to decide the class assignment is as follows: 
( )1 1 if 0.5.new new thc P c p∈ ∈ > =s s  
Otherwise, 2new c∈s . The threshold probability ( )thp  can be considered as a 
continuous variable to establish the Receiver Operator Characteristic (ROC) curve for 
this classifier [20]. Finally, the reduced base might be tested over different randomly 
chosen training and testing dataset, and averaging the results over a set of independent 
simulations. 
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Although this simple classifier seems to be similar to a nearest neighbor 
algorithm (k-NN), it is not obviously the same, since neither the centroid definition of 
the distributions, nor the way of adopting the decisions coincide. Besides, we have 
testing k-NN nearest neighbor classifiers without success. Notice that in this process, 
the feature selection method is executed only once using all training samples, before 
estimating the accuracy by means of a leave-one-out procedure. Our goal is to study 
the effectiveness of feature selection methods in finding the groups of prognosis 
variables with higher predictive accuracy of these two CLL-related problems. Also, if 
the attribute selection process was performed each time the classifier was executed 
(i.e. in each of the folds of the leave-one-out), different sets of attributes would be 
obtained, thus, it would more difficult to assess the goodness of any concrete group of 
prognosis variables. The only way will be performing frequency analysis of the 
selected prognostic variables and applying BFE to this set of variables ranked by 
decreasing order of their posterior frequency. Besides, since the accuracy is 
established by Leave-One-Out Cross Validation (LOOCV) the selected attributes 
within each fold of the LOOCV would not be so different from selecting them using 
the whole dataset, considering that the training set of each of fold in a LOOCV is 
composed by all the samples but one. These facts have been confirmed through 
numerical experimentation. 
 
2.4. ROC curves and risk assessment 
In the previous step, maximizing the predictive accuracy according to the 
LOOCV criterion allowed to determine the best reduced-base of prognostic variables. 
However, it is also important to analyze the structure of the confusion matrix, 
obtained from the set of predictions of the training set using the LOOCV method. The 
confusion matrix is composed by: True Positives (TP), True Negatives (TN), False 
Positives (FP) and False Negatives (FN). These concepts depend on how the 
classification problem is set up. From the confusion matrix we can calculate different 
rates that are very useful to understand the risk in the prediction: 
• True Positive Rate or Sensitivity (TPR): measures the proportion of actual 
positives that are correctly predicted as such. 
• True Negative Rate or Specificity (SPC): measures the proportion of negatives 
that are correctly predicted as such. 
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• Positive Predicted Value (PPV): is the proportion of positives values that are 
true positives. 
• False Positive Rate (FPR): fraction of false positives out of the total actual 
negatives. 
• False Negative Rate (FNR): fraction of false negatives out of the total actual 
positives. 
• False Discovery Rate (FDR): fraction of false positives out of the total actual 
positives. 
Based in these rates it is possible to construct a receiver operating characteristic curve 
(or ROC curve), which is a graphical plot that illustrates the performance of a binary 
classifier as a function of one parameter (the cut-off probability in this case). The 
curve is created by plotting the true positive rate or sensitivity (TPR) against the false 
positive rate (FPR) or fall-out. A perfect classifier has as ROC curve the step function 
at the origin. ROC analysis is related to cost/benefit analysis of diagnostic decision 
making (see for instance [17]). 
The selected attributes are used to provide simple biomedical discriminatory 
rules for diagnosis and prognosis since for each classification problem we provide the 
bounds for the four groups of the confusion matrix. This knowledge can be used by 
the physicians in their decision-making process. Additionally to the LOOCV results, 
we also provide the mean accuracy obtained for 100 random holdouts 75/25 (75% for 
training and 25% for testing). In any case, and independently of how the predictive 
accuracy is established, it is crucially important to understand that there exist different 
combinations of prognostic variables with similar predictive accuracy whose 
knowledge might be useful to understand the genesis of the problem from a medical 
point of view. The existence of these different lists is related to the uncertainty 
analysis of the solutions in any decision-making problem [21 -22].  
Finally, the aim of this paper is not to compare different machine learning 
methods, but to introduce a simple methodology to select the shortest list of 
prognostic variables that could be easily interpreted by medical doctors to perform 
prognostic predictions with their corresponding risk assessment. However, we have 
compared this distance based nearest-neighbor algorithm to more sophisticated 
learning methods and the results did not improve or were clearly worse. The success 
of the methodology is not based on the sophistication of the classifier but on selecting 
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the most discriminatory variables in each case and building the classifier based on 
these variables. By doing that it has been shown that the classification problem 
becomes linearly separable [23]. 
The methodology presented herein is easy to understand, since we avoid the use 
of black-box methodologies that provide estimations without MD’s understanding, 
and has been successfully applied to predict response to treatment in Hodgkin 
lymphoma [17] using clinical data, and also in the prediction of risk of radiotherapy-
related fatigue in prostate cancer patients using high dimensional expression data [24]. 
 
3. RESULTS AND DISCUSSION 
3.1. Chemotherapy Treatment Assessment 
As it was already mentioned CLL has a highly variable clinical course. Some 
patients have an indolent disease and they do not require CT. Other patients who 
present a progressive disease may require an intense CT. The identification of those 
patients at early stages of the disease with a high risk of rapid disease progression 
may help to significantly improve their prognosis. Thus, we try to establish the 
prognostic variables and criteria to assess the need for CT, assuming that the clinical 
decisions on the 71 (out of 259, therefore there are 6 missing values since the total 
cohort is 265) patients that have received CT were correct. The criteria for initiating 
CT were established in 2008 by the International Workshop on Chronic Lymphocytic 
Leukemia [25]. Particularly the presence of constitutional symptoms, such as, 
unintentional weight loss of 10% or more within the previous 6 month and significant 
fatigue or fevers or night sweats without other evidence of infection. 
The Fisher’s ratio method provided the minimum-size set of prognostic 
variables with the highest accuracy of 80.3%: B2M, WBC, ALC and MBC. Figure 2 
shows the ROC curve and the Recall (or True Positive Rate -TPR) against Precision 
(or Positive Predicted Value - PPV) curves for several probability thresholds in the 
CT classification problem. The optimum result (pth = 0.47) shows that 63.4% (TPR) of 
the patients that need CT and 86.7% (True Negative Rate or Specificity – SPC) of the 
patients that do not need CT were correctly predicted. Besides, with that probability 
threshold we got a Precision (or Positive Predicted Value – PPV) of 64.3%. 
Nevertheless, other probability thresholds could be adopted depending on the 
Recall/Specificity balance, and therefore on the PPV as well. The False Discovery 
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Rate (FDR) was 36.62%. The confusion matrix is shown below:  
45 25
.
26 163
TP FP
FN TN
⎛ ⎞ ⎛ ⎞
=⎜ ⎟ ⎜ ⎟
⎝ ⎠ ⎝ ⎠
 
The True Positives (TP) are formed by the group of patients that need CT (+) and are 
correctly predicted, and the True Negatives (TN) are formed by the groups of patients 
that do not need CT (-) and are correctly predicted. Thus, False Positives (FP) are the 
patients that do not need CT (-) and are not correctly predicted and False Negative 
(FN) are the patients that need CT (+) and are not correctly predicted.  
Besides, we have performed a two sample T-test and a Mann-Whitney U-test to 
clarify the differences between the TP and TN groups in the selected variables. The 
null hypothesis was rejected for all the prognostic variables. Therefore their statistical 
distributions should be considered to be different and the differences to be significant 
(see Appendix).  
Additionally the Maximum Percentile Distance method also found a subset of 
variables with lower accuracy (78%): MBC, ALC, ZAP70, WBC and B2M. 
Moreover, the results using the minimum class Entropy were quite similar (76.8%): 
ZAP70, BU, WBC, ALC and MBC.  
CT is recommended in patients with advanced and progressive disease. Thus, 
the amount of malignant leukemia cells that it is measured by the different counts of 
leucocytes; particularly WBC (White Blood Cells count), ALC (Absolute 
Lymphocyte Count) and MBC (Monoclonal B Cell Count) are key clinical 
parameters. Nevertheless, these variables are not currently used to select patients who 
may benefit from CT. On the other hand, AGE, B2M and ZAP70 are traditional 
clinical parameters that have demonstrated their prognostic importance independently 
of the clinical stage. Our results also indicated the great prognostic significance of 
other variables that are mainly related with the characteristics of the immune system 
and are not currently used as prognostic markers in this disease. The fact that the 
prediction accuracy is barely above 80% means that these variables only contain 
partial information to establish the need of CT and/or to incorrect medical decisions 
that might input noise in the class assignment. 
Table 2 shows the median/mean signatures for the 4 groups of the confusion 
matrix for the main decision variables found by this methodology. We can observe 
that there exists a significant distance between the mean signatures of the TP and TN 
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groups, being the median/mean signatures in all the decision variables much higher in 
the TP group. Moreover, the distance between the median and the mean values of the 
decision variable distributions is much higher in the TP and in the FP groups, 
meaning a higher variability in these groups: 
• The normal value of B2M is less than 2 mg/L [26]. Levels of B2M can be 
elevated in multiple myeloma and lymphoma. Besides, elevated values (>4 
mg/L) are known to be an indicator of poor prognosis and survival [27]. In our 
case B2M is higher than this cut-off value (4.24) for the patients in the TP 
group.  
• For the second decision variable, the normal value of WBC in the blood is 4.5-
10.0 Kcells/microL. In our case the patients of the TN group have a mean 
WBC value (16.8 Kcells/microL) that exceeds four times the minimum normal 
value. Also the patients in the TP group show even higher mean WBC values 
(61.8 Kcells/microL).  
• The reference range for the ALC is 4.5-11.0 Kcells/microL. It can be also 
observed that the ALC mean value in the TP group (47.6 Kcells/microL) 
exceeds 4 times the maximum normal value. 
• Finally, the MBC is also very high (40.3 Kcells/microL) in the TP group 
compared to the TN group (8.4 Kcells/microL). The definition of CLL implies 
having a rate of CLL-phenotype B-cell lymphocytes higher than 5 
Kcells/microL. 
 
This analysis shows the typical profile of CLL patients with need of CT. The same 
tendencies are observed for the corresponding median values. 
With respect to the analysis of the classification errors, the mean signatures of the FN 
group (patients that need CT and are incorrectly predicted) are very close to the mean 
signatures of the TN group. These patients will never be correctly predicted according 
to this classifier. The mean and median signatures of the FP group have the following 
singularities:  
1. The mean B2M value (4.58 mg/L) is even higher than the corresponding 
B2M mean value in the TP group (4.24 mg/L). The same is observed for the 
median values. 
2. Their mean WBC, ALC and MBC values are closer to the corresponding 
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mean values of the TN group, exceeding in all the cases the mean values of the 
TN group. These differences are smaller in the case of the median values. 
These patients could be detected using only these three variables, not 
considering the value of B2M in these patients that is distorting the prediction.  
 
Furthermore, to understand the ambiguity in the CT prediction, it should be taken into 
account that the criteria used to establish the need of CT [25] sometimes have not 
correlation with the biological data. The reason is that some patients are diagnosed in 
early stages of the disease when a low burden tumor mass has been detected but they 
have a very fast progression which implies the need of CT. 
 
3.2. Autoimmune Disease development 
An autoimmune disease (AD) occurs when an adaptive immune response is 
mounted against self-antigen. In CLL, an autoimmune response against red blood 
cells (known as autoimmune haemolytic anemia), and an autoimmune response 
against platelets (known as immune thrombocytopenia) are severe complication of 
this disease. To the best of our knowledge no prognostic factors capable to predict the 
presence or development of an autoimmune disease in CLL patients have been 
currently disclosed. In our cohort only 16 patients (out of 263, therefore there are 2 
missing values since the total cohort is 265) have shown autoimmune disorders. 
Therefore this classification problem, independently of the data sampling, is 
intrinsically highly unbalanced. 
 The shortest list of prognostic variables with the highest accuracy (97.3%) was 
found by the Fisher’s ratio method and includes 13 clinical variables: PLT, RET, 
ALB, HGB, BU, UR, MCV, NCC, K, WBC, LDH, ALC and MBC. Furthermore, 
considering only the first nine attributes the predictive accuracy was 95.4%. Besides, 
only the two first attributes provided a predictive accuracy of 91%. Figure 3 shows the 
ROC and the Recall (or True Positive Rate -TPR) against Precision (or Positive 
Predicted Value - PPV) curves throughout all possible probability thresholds for the 
AD classification problem. The optimum result (pth = 0.5) shows that 62.5% (TPR) of 
the patients that have AD and 99.6% (True Negative Rate or Specificity -SPC) of the 
patients that do not have AD are correctly predicted. Moreover, over that probability 
threshold we get a Precision (or Positive Predicted Value – PPV) of 90.1%. However, 
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other probability thresholds could be adopted depending on the Recall/Specificity 
balance, and therefore on the PPV as well. The False Discovery Rate (FDR) in this 
case is 9.1%. The confusion matrix is the following one:  
10 1
.
6 246
TP FP
FN TN
⎛ ⎞ ⎛ ⎞
=⎜ ⎟ ⎜ ⎟
⎝ ⎠ ⎝ ⎠
 
The True Positives (TP) group is formed in this case by the patients that present AD 
(+) and are correctly predicted and True Negatives (TN) correspond to the patients 
that do not have AD (-) and are correctly predicted. Similarly, the False Positives (FP) 
are the patients that do not have AD (-) and are not correctly predicted and the False 
Negatives (FN) correspond to the patients that present AD (+) and are not correctly 
predicted. As in the previous section, we have performed the T-test and the Mann-
Whitney U-test to analyze the differences between the TP and TN groups. The null 
hypothesis was rejected for all selected variables, except for K and LDH in the T-test 
(see Appendix). 
Additionally the percentile distance method also found a subset of variables with 
95.1% accuracy composed only by one prognostic variable: NCC. Entropy method 
also found a subset of 4 prognostic variables with 94.3% accuracy: TLC, T8C, NCC 
and MBC. PLT and RET, that were ranked in the first positions by the Fisher’s Ratio, 
were found by the Entropy method in the fifth and sixth positions (TLC, T8C, NCC, 
MBC, RET and PLT), but the accuracy of this final subset was 93.2%. 
PLT and RET appears in the first two positions of the FR list. They are 
responsible for most of the discriminatory power of the reduced base of features and 
the rest of variables span high frequency details in the classification. They also appear 
in the first positions of the list using Entropy method. It seems they could have an 
important role in the development of an autoimmune disease. Table 3 shows the 
medians and means for the 13 prognostic variables for the 4 groups of the confusion 
matrix. The differences between the means in TP and TN groups decrease with the 
Fisher’s ratio. Prognostic variables with lower Fisher’s ratios (secondary variables) 
also contribute to improve the discrimination. Except for the main variable, PLT, and 
the secondary variables HGB and K, the mean and median values are higher in the 
group with autoimmune disease (TP). The analysis of the two main prognostic 
variables shows that patients that develop AD and are correctly predicted (TP) have 
much lower medians and means PLT values (97.7/95.0 Kcells/microL). The normal 
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platelet count lays in the range 150-450 Kcells/microL, being the average 237 
Kcells/microL in men, and 266 in women. On the other hand, the reticulocyte count 
(RET) in the TP group almost doubles (136 Kcells/microL) the average RET count in 
patients with no AD (70 Kcells/microL). Median values also show similar tendencies.  
The False Positives (FP group) is composed in this case only by 1 sample, 
whose signature is closer for all the 13 variables to the TP group, except for PLT, 
RET that are somewhere in between the median/mean values for TP and TN. This fact 
points out the difficulty of classifying this sample, and it can be concluded that it 
could be a ’biological’ outlier. On the other hand, the FN group is composed by 6 
samples. The mean PLT count (147 Kcells/microL) of the FN group lies between the 
mean value for the TP (95 Kcells/microL) and TN (202.2 Kcells/microL) groups. The 
RET count is however closer to the TN group showing a tendency to very low median 
values (54.4 Kcells/microL). 
The percentile distance method found a subset of variables with 95.1% accuracy 
composed only by the Natural killer Cell Count (NCC). The mean NCC value in the 
TP group (2251 cells/microL) is higher than in the TN (741 cells/microL) and FN 
(393 cells/microL) groups. Natural killer cells provide rapid responses to virally 
infected cells and respond to tumor formation. Therefore, this result suggests a 
possible link between AD development, viral infection and tumor progression. The 
percentile method also gives a great importance to IgM due to the higher values in the 
group of patients without AD (TN group with a mean of 1.12 g/L) with respect to the 
TP group (mean value of 0.36 g/L). This result is important since IgM is the first 
antibody to appear in response to initial exposure to antigens [28] and lower levels of 
this inmunglobulin is related to selective immunoglobulin M deficiency, which in turn 
is also related with autoimmune disorders like celiac disease or systemic lupus 
erythematosus [29]. 
Overall, these results show the importance of variables associated with the 
characteristics of platelets and red cells, which are the main targets of the autoimmune 
haemolytic anemia and immune thrombocytopenia, such as PLT, HGB, MCV and 
RET. Other variables depend on the presence of autoantibodies (COOMBS) or 
products or symptoms derived from the lysis of blood cells (BU, LDH and SMG). 
Moreover, some variables associated with the immunological characteristics of 
patients, such as IgM, IgG, IgA, TLC, NCC and T8C, constitute a relevant subset of 
variables that may predict an autoimmune disease occurrence. The association of 
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these variables with an autoimmune disease is not unexpected based on the biology of 
CLL, but we would like to highlight that no prognostic factors or system may 
currently predict the development of an autoimmune disease in the clinical practice. 
To the best of our knowledge this is the first description so far that a group of clinical 
variables obtained at diagnosis of CLL patients may predict an occurrence of an 
autoimmune disease. 
 
3.3. Summary of the results 
Finally, Table 4 summarizes the main results found for both classification 
problems (CT and AD): the optimum reduced set of features, the LOOCV accuracy, 
the hold out (HO) mean accuracy over 100 different random simulations using 75% 
and 25% of samples for training and testing, the Sensitivity or True Positive Rate 
(TPR), and the Specificity or True Negative Rate (SPC) statistics. TPR and SPC 
values are important due to the impact on the patients of the decision taken by 
physicians.  
It is possible to observe that:  
1. The median accuracy of the predictions is quite stable with respect to the 
LOOCV accuracy. 
2. The TPR/SPC statistics are optimally balanced in all the problems. The 
TPR/SPC statistics might be the target of a different optimization for the 
weights of the linear classifier depending on the risk that is given by the 
medical doctors to the False Positives (FP) and False Negatives (FN) 
diagnostic in each classification problem. This approach has been adopted to 
predict response to treatment in Hodgkin Lymphoma [17]. 
 
4. CONCLUSIONS 
Different prognostic factors are presented in this paper to predict two clinically 
important classification problems for CLL patients: Chemotherapy Treatment 
assessment and Autoimmune Disease development. 
From the machine learning point of view, working imputed data produced better 
results in reliability (accuracy) than working with raw data. Fisher’s ratio and 
percentile distance are the feature selection methods that produced the best 
biomarkers in terms of medical interpretability. The minimum-size of variables is 
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established using BFE. The class prediction is based on a simple classifier, and its 
accuracy is determined by LOOCV experiment. The results show that the accuracies 
are rather high and the difference between both experiments LOOCV and 100 
repetitions of a Hold Out (75/25) is quite low, which highlights the robustness of the 
methodology. In addition, risk assessment ROC curves are provided for each problem 
and show a good balance between False Positives and False Negatives. 
From a medical point of view, machine learning methods allow the 
identification of clinical variables obtained at diagnosis of CLL patients, which may 
predict the development of AD and the need of CT. These variables are obtained at 
diagnosis of CLL patients on a regular basis, and consequently, their use does not 
increase the cost or complexity of the diagnosis in CLL patients. The need of CT 
seems to be related to the amount of malignant leukemia cells that are measured by 
the different leucocytes counts.  
The best prognostic variables to predict the need of CT were B2M, WBC, ALC 
and MBC. Although the results concerning these prognostic variables are well known 
in other plasma disorders, this analysis served to conclude that these variables only 
carry partial information to adopt this important decision, that most of the times, is 
taken based on criteria that have not correlation with the biological data. To the best 
of our knowledge this is the first description so far that a group of clinical variables 
obtained at diagnosis of CLL patients may predict an occurrence of an AD, which is a 
severe and currently unpredictable complication of this disease. These results show 
the importance of variables associated with the characteristics of platelets, 
reticulocytes and natural killers (PLT, RET and NCC), which are the main targets of 
the autoimmune haemolytic anemia and immune thrombocytopenia. Additionally, 
machine learning methods focus on the relevance of some variables, such as the 
immunological ones, which may have an important impact on the prognosis of CLL 
patients, but they are not currently used by hematologists. Particularly, this analysis 
has shown that the low sampling frequency of RET and ZAP-70 could be troubling 
given their predictive significance in all the problems that have been treated: RET is a 
key factor for predicting AD, whilst ZAP-70 seems to be important for predicting the 
need of CT. 
In conclusion, machine learning methods allow an accurate prediction of risk in 
CLL related problems. Additionally, they may establish the relevance of clinical 
variables that are not widely used as prognostic factor in this disease. The prognostic 
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significance of these variables may probably reflect the relevance of some clinical 
aspects of this disease that are more important for prognosis than it is currently 
thought. This bioinformatics system can be easily applied in medical practice and 
updated along time through a simple computer program or excel spreadsheet (see 
supplementary material file “CLL_predictor.xls”). 
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LIST OF CAPTIONS 
Figure 1: Methodology flowchart. 
 
Figure 2: A) ROC curve. B) Sensitivity (or True Positive Rate -TPR) and Precision 
(or Positive Predicted Value - PPV) for Chemotherapy Treatment. The optimum result 
(TPR = 63.4 and PPV = 64.3) is obtained for pth = 0.47.  
 
Figure 3: A) ROC curve. B) Sensitivity (or True Positive Rate -TPR) and Precision 
(or Positive Predicted Value - PPV) for Autoimmune Disease occurrence. The 
optimum result (TPR = 62.5 and PPV = 90.1) is obtained for pth = 0.5. 
 
